http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107398301-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-0213 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-2239 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-1691 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-33 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-33 |
filingDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107398301-B |
titleOfInvention | Catalyst for converting ethyl levulinate into gamma-valerolactone and preparation method thereof |
abstract | A catalyst for converting ethyl levulinate into gamma-valerolactone comprises two parts, sulfonic acid functionalized hafnium-metal organic framework material SO 3 H-MOF (Hf) and noble metal Ru nano particles, wherein the content of the noble metal Ru is 0.5-5% by weight of the total weight of the catalyst, and a sulfonic acid group SO 3 The content of H is 0-20% of the total weight of the catalyst. The preparation method comprises the steps of adding hafnium tetrachloride, terephthalic acid and 2-sulfonic acid terephthalic acid monosodium salt into a mixed solution of dimethyl formamide and acetic acid, crystallizing, washing and drying to obtain a sulfonic acid functionalized metal organic framework material SO 3 H-MOF (Hf); RuCl was added dropwise 3 The solution is used for obtaining a catalyst precursor, and the catalyst precursor is subjected to sodium borohydride reduction and hydrochloric acid post-treatment to obtain the catalyst. The catalyst has better catalytic activity, selectivity and reusability when being used for converting ethyl levulinate into gamma-valerolactone. |
priorityDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.